Clinical trials

Condition   Drug Name  
Study MAS-063D in eczema: The NCT00488241 study
Design Open; Multicenter
Patients 40
Treatment Regimen MAS-063D
Conclusions The safety and efficacy of MAS-063D in patients with hand eczema will be assessed in a phase lV study initiated in June 2007 and expected to be completed by March 2008
Reference(s) Multicenter clinical study to examine the efficacy and safety of zarzenda in patients with hand eczema (NCT00488241) Web Site 2007